BRVE - Braveheart Bio, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - BRVE (2131524)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2026-08-07
BRVEForbion Growth Opportunities Fund III Cooperatief U.A.10%P - Purchase$18.00+3,600,00021,826,024+20%+$64,800,000
D
2026-08-07
BRVERickey James PaulCFOP - Purchase$18.00+27,777703,575+4%+$499,986
D
2026-08-07
BRVEViehbacher ChristopherDirP - Purchase$18.00+83,333759,857+12%+$1,499,994
D
2026-08-07
BRVEMalek David IDirP - Purchase$18.00+4,1661,013,2970%+$74,988
D
2026-08-07
BRVEAnderson Michele A.Chief Development OfficerP - Purchase$18.00+1,111332,1610%+$19,998
D
2026-08-07
BRVEMurdoch TravisCEO, PresP - Purchase$18.00+83,3338,333,637+1%+$1,499,994
D
2026-08-07
BRVELubner David CharlesDirP - Purchase$18.00+55,55555,555New+$999,990

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top